ARL13B (Gene)

Synonyms:ADP ribosylation factor like GTPase 13B, ARL13B, ARL2L1, ENTREZ:200894, HGNC:25419, JBTS8, MIM:608922, NM_001174150, NM_001174151, NM_001321328, NM_144996, NM_182896, NP_001167621, NP_001167622, NP_001308257, NP_659433, NP_878899, NR_033427, NR_135621, XM_006713532, XM_011512532, XM_011512533, XM_011512534, XM_011512535, XM_017005853, XP_006713595, XP_011510834, XP_011510835, XP_011510836, XP_011510837, XP_016861342
Omim:OMIM:608922
Id:ENSG00000169379
Hgnc:HGNC:25419
Entrez:200894
Description:ARF like GTPase 13B
This gene encodes a member of the ADP-ribosylation factor-like family. The encoded protein is a small GTPase that contains both N-terminal and C-terminal guanine nucleotide-binding motifs. This protein is localized in the cilia and plays a role in cilia formation and in maintenance of cilia. Mutations in this gene are the cause of Joubert syndrome 8. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ARL13B's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ARL13B.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ARL13B.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ARL13B.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ARL13B.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.